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Abstract
Dry pleural dissemination in non-small cell lung cancer, defined as solid pleural metastasis of
lung cancer without pleural eff usion, is a condition occurring in T4 lung cancer. Positron emission
tomography (PET) has been reported to be useful for the diagnosis and staging of lung cancer. It
has been reported that positive findings on PET scans of indeterminate pleural abnormalities at
computed tomography (CT) are sensitive to malignancy. We encountered two cases of dry small
pleural dissemination of adenocarcinoma of the lung preoperatively detected by PET/CT. A 75-
year-old man and a 66-year-old man underwent CT scan, which demonstrated solitary tumor in
the lung, an enlarged mediastinal lymph node, and a small pleural nodule less than 10 mm in size,
all of which were positive findings on the fluorine 18 fluorodeoxyglucose (FDG) PET portion of
an integrated PET/CT. Both patients underwent thoracoscopic biopsy of the dry pleural nodule
revealing dissemination of adenocarcinoma of the lung (T4). Whereas histological thoracoscopic
diagnosis remains mandatory before planning treatment, our cases may suggest that PET/CT will
be useful as a screening modality for dry pleural dissemination of lung cancer.
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n the management of non-small cell lung cancer 
(NSCLC),  obtaining an accurate staging of the 
disease is important to treating patients appropriately 
[1].  Dry pleural dissemination in NSCLC,  deﬁ ned as 
solid pleural metastasis of lung cancer without pleural 
eﬀ usion is a condition occurring in T4 lung cancer.  
Positron emission tomography (PET) with the labeled 
glucose analogue ﬂ uorine 18 ﬂ uorodeoxyglucose 
(FDG) is known to map both normal and abnormal tis-
sue function,  and complements computed tomography 
(CT) imagining,  which allows for the viewing of exqui-
site anatomic details.  When combined,  these 2 modal-
ities can help both identify and localize functional 
abnormalities.  There have been a couple of papers 
about the role of an FDG PET in pleural diseases 
showing that positive ﬁ ndings on FDG PET scan of 
indeterminate pleural abnormalities at CT are sensi-
tive to malignancy [2].  We report herein 2 cases of 
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Dry pleural dissemination in non-small cell lung cancer,  deﬁ ned as solid pleural metastasis of lung 
cancer without pleural eﬀ usion,  is a condition occurring in T4 lung cancer.  Positron emission tomog-
raphy (PET) has been reported to be useful for the diagnosis and staging of lung cancer.  It has been 
reported that positive ﬁ ndings on PET scans of indeterminate pleural abnormalities at computed 
tomography (CT) are sensitive to malignancy.  We encountered two cases of dry small pleural dis-
semination of adenocarcinoma of the lung preoperatively detected by PET/CT.  A 75-year-old man 
and a 66-year-old man underwent CT scan,  which demonstrated solitary tumor in the lung,  an 
enlarged mediastinal lymph node,  and a small pleural nodule less than 10 mm in size,  all of which were 
positive ﬁ ndings on the ﬂ uorine 18 ﬂ uorodeoxyglucose (FDG) PET portion of an integrated PET/CT.  
Both patients underwent thoracoscopic biopsy of the dry pleural nodule revealing dissemination of 
adenocarcinoma of the lung (T4).  Whereas histological thoracoscopic diagnosis remains mandatory 
before planning treatment,  our cases may suggest that PET/CT will be useful as a screening modality 
for dry pleural dissemination of lung cancer.
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dry small pleural dissemination of adenocarcinoma of 
the lung that were preoperatively detected by PET/
CT.
Case Report
　 Case 1. A 75-year-old man with a past medical 
history of pneumoconiosis underwent a CT scan show-
ing a 25-mm solitary tumor in the left upper lobe,  an 
enlarged mediastinal lymph node,  and a small pleural 
nodule 9 mm in size on the left mediastinal side,  all of 
which were positive ﬁ ndings on the FDG PET portion 
of an integrated PET/CT (Fig. 1).  The maximum 
standardized uptake values (SUV (max)) of the pri-
mary tumor and the small pleural nodule were 8.64 
(early phase) and 9.97 (late phase),  respectively,  in the 
primary tumor,  and 3.01 (early phase) and 3.41 (late 
phase) in the pleural nodule.  The diagnosis of adeno-
carcinoma was conﬁ rmed by CT-guided biopsy of a 
solitary tumor in the left upper lobe.  Video assisted 
thoracic surgery (VATS) biopsy of a small pleural 
nodule was performed.  As a histologic examination of 
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Fig. 2　　PET/CT evaluation of both a pulmonary tumor and a dry small pleural nodule in a 66-year-old man.  A,  PET scan shows intense 
focal FDG uptake on a pulmonary tumor; B,  CT scan shows a pulmonary tumor 55 mm in size; C,  PET scan shows intense focal FDG 
uptake on a small pleural nodule (arrow); D,  CT scan shows a pleural nodule 7 mm in size (arrow).
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Fig. 1　　PET/CT evaluation of both a pulmonary tumor and a dry 
small pleural nodule in a 75-year-old man.  A,  PET scan shows 
intense focal FDG uptake on a pulmonary tumor and a small pleural 
nodule (arrow); B,  CT scan shows a pulmonary nodule 25 mm in 
size and a pleural nodule 9 mm in size (arrow).
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the biopsy specimen demonstrated adenocarcinoma,  
his staging was ﬁ nally classiﬁ ed as p-Stage IIIB 
(T4N0M0).  Systemic chemotherapy was then initiated 
with carboplatin and gemcitabine.
　 Case 2. The patient was a 66-year-old man with 
liver cirrhosis.  During a regular check-up,  a 55-mm 
mass shadow in the right lung was detected on his 
chest X-ray ﬁ lm.  CT scan revealed a tumor in the 
region of right S1,  an enlarged mediastinal lymph 
node,  and a small pleural nodule 7 mm in size on the 
right mediastinal side (Fig. 2).  FDG PET ﬁ ndings at 
integrated PET/CT also demonstrated an accumula-
tion corresponding to these lesions (Fig. 2).  SUV 
(max) of the primary tumor and the small pleural nod-
ule were 20.0 (early phase) and 27.6 (late phase) in the 
primary tumor,  and 3.27 (early phase) and 3.98 (late 
phase) in the pleural nodule,  respectively.  A biopsy 
specimen of the small pleural nodule was obtained 
under VATS.  The pleural abnormality proved patho-
logically to be dissemination of adenocarcinoma of the 
lung (T4).  He was considered a poor candidate for 
surgical intervention,  and systemic chemotherapy con-
sisting of carboplatin and paclitaxel was begun.
Discussion
　 In patients with NSCLC,  pleural dissemination is 
considered a contraindication to surgical treatment.  
The diﬀ erentiation of a small dry pleural nodule 
between benign and malignant is important for accu-
rate staging and appropriate therapeutic strategies.  
Currently,  CT scan has been the mainstay of assess-
ment of dry pleural dissemination; this assessment,  
however,  is based on morphological criteria and can 
therefore be misleading.  It has been reported that 
71ｵ of the pleural abnormalities examined by CT 
scan are classiﬁ ed as indeterminate [1].
　 FDG PET has been extensively used in the assess-
ment of lung cancer [2].  A signiﬁ cant improvement in 
the evaluation of lymph node metastasis and distant 
metastasis has been shown in comparison to CT scan 
[3].  Moreover,  FDG PET seems to have great 
potential in the diﬀ erential diagnosis of pleural dis-
eases.  Several studies have reported the role of FDG 
PET with identiﬁ cation of pleural malignancies [4ﾝ6].  
According to Bury et al. the speciﬁ city and sensitivity 
were found to be 78ｵ and 100ｵ,  respectively,  in 25 
patients with benign and pleural diseases [4].  Benard 
et al. have reported favorable results in the diﬀ erential 
diagnosis between benign and malignant with a speci-
ﬁ city of 100ｵ and a sensitivity of 91ｵ [5].  An SUV 
threshold of 2 has been proposed as a distinguishing 
point between benign and malignant diseases with an 
accuracy of 92ｵ [6].  While these data are encourag-
ing,  there are a couple of limitations of FDG PET to 
be considered.  First,  nonmalignant processes such as 
tuberculosis,  fungal infections,  sarcoidosis,  and 
pneumoconiosis can take up FDG and mimic the 
appearance of a malignant nodule on PET or PET/CT 
images.  It is therefore necessary to obtain details 
about the patient regarding exposure,  as well as per-
tinent medical history.  In addition,  in order to obtain 
a deﬁ nite diagnosis,  biopsy would be required because 
FDG PET cannot reliably help in distinguishing 
between benign and malignant pulmonary nodules.  
Secondly,  false-negative scans of pleural dissemina-
tion can be seen due to a limited resolution of PET 
for 6ﾝ12 mm lesions [2],  as can a decreased maxi-
mum SUV related to respiratory motion [7].  Shim 
and colleagues have demonstrated that,  by PET only,  
the sensitivity,  speciﬁ city,  and accuracy of dry small 
pleural dissemination are 25ｵ (2/8),  90ｵ 
(147/164),  87ｵ (149/172),  respectively; by PET 
plus CT,  these were 100ｵ (8/8),  100ｵ (164/164),  
100ｵ (172/172),  respectively [7].  The CT portion 
of an integrated PET/CT helps improve the diagnos-
tic accuracy of dry pleural nodules.  Whereas histo-
logical thoracoscopic diagnosis remains mandatory 
before planning treatment,  our cases may suggest that 
PET/CT should be considered useful as a screening 
modality for dry pleural dissemination of lung cancer.
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